4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-344682
CEO acquired 4,363 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Weis Holger CEO | 2026-08-06 | Grant or award | +4,363 | $2.01 | $8,770 | 25,483 | D |
Loading xslF345X06/ownership.xml…